| Literature DB >> 34143368 |
Nicoletta Mancianti1, Andrea Guarnieri2, Sergio Tripodi3, Domenica Paola Salvo1, Guido Garosi1.
Abstract
Entities:
Keywords: BioNTech/Pfizer vaccine; COVID-19; Glomerular disease; Minimal change disease; SARS-CoV-2 vaccine
Year: 2021 PMID: 34143368 DOI: 10.1007/s40620-021-01091-1
Source DB: PubMed Journal: J Nephrol ISSN: 1121-8428 Impact factor: 3.902